N@N

Gary Nachman Initiated (ALNY) at Buy and Held Target at $208 on, Sep 29th, 2023

Gary Nachman of Raymond James, Initiated "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy and Held Target at $208 on, Sep 29th, 2023.

Gary has made no other calls on ALNY in the last 4 months.

There are 8 other peers that have a rating on ALNY. Out of the 8 peers that are also analyzing ALNY, 2 agree with Gary's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Olivia Brayer of "Cantor Fitzgerald" Reiterated at Hold and Held Target at $190 on, Thursday, September 14th, 2023
• Michael Ulz of "Morgan Stanley" Reiterated at Hold and Held Target at $210 on, Friday, August 4th, 2023

These are the ratings of the 6 analyists that currently disagree with Gary

---

• Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $405 on, Monday, September 18th, 2023
• Paul Matteis of "Stifel" Reiterated at Strong Buy and Held Target at $240 on, Thursday, September 14th, 2023
• Joseph Stringer of "Needham" Reiterated at Strong Buy and Held Target at $240 on, Thursday, September 14th, 2023
• Luca Issi of "RBC Capital" Reiterated at Buy and Held Target at $270 on, Tuesday, September 12th, 2023
• Keay Nakae of "Chardan Capital" Reiterated at Strong Buy and Held Target at $250 on, Tuesday, August 8th, 2023
• David Lebovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $266 on, Friday, August 4th, 2023

Contributing Sources

---